Prot#MCC-12215(X05240)//NU VC11H12: Phase I Study of Bortezomib and Romidepsin in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Indolent B-Cell Lymphoma, or Peripheral T-Cell Lymphoma

Project: Research project

Project Details

StatusFinished
Effective start/end date6/6/12 → 6/6/15

Funding

  • Virginia Commonwealth University (MCC-12215(X05240)//NU VC11H12)
  • Millennium Pharmaceuticals, Inc (MCC-12215(X05240)//NU VC11H12)
View all
View less